Cardiovascular Research

Factors that influence the proportions of platelet-activating factor and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine synthesized

Authors: M Triggiani|||A N Fonteh|||F H Chilton

Affiliations: + Expand

Abstract

Recent studies have demonstrated that inflammatory cells can be divided into two groups depending on the type of 2-acetylated phospholipids [1-radyl-2-acetyl-sn-glycero-3-phosphocholine (GPC)] they produce: those that produce predominantly platelet-activating factor (PAF), and those that produce predominantly its 1-acyl analogue (1-acyl-2-acetyl-GPC; AAGPC) [Triggiani, Schleimer, Warner & Chilton (1991) J. Immunol. 147, 660-666]. The present study has examined the factors that regulate the production of these two molecules in mouse bone marrow-derived mast cells (BMMC). Initial experiments indicated that PAF and AAGPC were catabolized by BMMC in a differential manner via two pathways: the first, exclusive for AAGPC, involved a 1-acyl hydrolase that removed the long chain at the sn-1 position of the molecule, and the second, common to AAGPC and PAF, involved acetylhydrolase that removed the acetate at the sn-2 position of the two molecules. Experiments were next designed to identify conditions where the differential catabolism of AAGPC and PAF could be eliminated in order to uncover other factors that regulate the proportions of AAGPC and PAF produced. Phenylmethanesulphonyl fluoride (PMSF) completely blocked the 1-acylhydrolase activity while having little or no effect on the acetyl hydrolase activity, thereby eliminating the influence of the catabolic pathway unique to AAGPC. Moreover, PMSF did not alter the release of arachidonic acid from phospholipid subclasses. PMSF-treated BMMC produced larger quantities of AAGPC than of PAF. The AAGPC/PAF ratio detected in PMSF-treated BMMC was very similar to the ratio of arachidonate contained in and released from 1-acyl-/1-alkyl-linked phosphatidylcholine (PC). BMMC supplemented with arachidonic acid in culture for 3 days increased their total arachidonic acid content in PC as well as the ratio of 1-acyl-2-arachidonoyl-GPC to 1-alkyl-2-arachidonoyl-GPC. These changes resulted in parallel and significant increases in both the total amount of 1-radyl-2-acetyl-GPC and the AAGPC/PAF ration in BMMC. These data indicate that the AAGPC/PAF ratio produced by inflammatory cells is regulated by at least two factors: (1) differential catabolism of these two molecules, and (2) the distribution of arachidonate in 1-acyl- and 1-alkyl-2-arachidonyl-GPC. These observations support the concept of a common pathway for AAGPC and PAF biosynthesis in which the two precursor molecules are 1-acyl-2-arachidonoyl-GPC and 1-alkyl-2-arachidonoyl-GPC, respectively.

---

Chemical List

1-acyl-2-acetyl-sn-glycero-3-phosphocholine|||Platelet Activating Factor|||Arachidonic Acid|||Phosphorus|||Calcimycin|||Phenylmethylsulfonyl Fluoride

---

Reference List

J Biol Chem. 1991 May 5;266(13):8268-72|||J Biol Chem. 1991 Apr 15;266(11):6928-35|||J Biol Chem. 1990 Apr 5;265(10):5409-13|||J Biol Chem. 1990 Jul 25;265(21):12363-71|||J Biol Chem. 1990 Aug 25;265(24):14654-61|||J Immunol. 1990 Jun 15;144(12):4773-80|||J Immunol. 1990 Oct 1;145(7):2241-8|||Biochim Biophys Acta. 1989 Dec 8;993(2-3):148-56|||J Biol Chem. 1986 Jun 15;261(17):7592-5|||Biochem Biophys Res Commun. 1987 Jun 30;145(3):1126-33|||Am Rev Respir Dis. 1986 Apr;133(4):614-7|||J Immunol. 1986 May 1;136(9):3441-6|||Biochim Biophys Acta. 1985 Jan 9;833(1):111-8|||J Immunol. 1983 Dec;131(6):2958-64|||Biochim Biophys Acta. 1983 May 16;751(3):298-304|||Biochem Biophys Res Commun. 1983 May 31;113(1):72-9|||Biochim Biophys Acta. 1984 Oct 24;796(1):92-101|||Biochim Biophys Acta. 1982 Sep 14;712(3):667-76|||Res Commun Chem Pathol Pharmacol. 1982 Oct;38(1):3-20|||Can J Biochem Physiol. 1959 Aug;37(8):911-7|||J Biol Chem. 1980 Nov 10;255(21):10256-60|||Lipids. 1966 Jan;1(1):85-6|||J Biol Chem. 1989 May 25;264(15):8467-70|||Biochem Biophys Res Commun. 1987 May 14;144(3):1243-50|||Biochim Biophys Acta. 1988 Dec 16;963(3):476-92|||J Biol Chem. 1987 Jan 25;262(3):1199-205|||J Biol Chem. 1985 Jul 5;260(13):7889-95|||J Biol Chem. 1983 May 25;258(10):6213-8|||J Biol Chem. 1984 Oct 10;259(19):12014-9|||J Lipid Res. 1982 Jan;23(1):190-6|||Anal Biochem. 1976 May 7;72:248-54|||Biochim Biophys Acta. 1991 Jun 19;1084(1):41-7|||Biochim Biophys Acta. 1991 Sep 11;1085(2):191-200|||Biochim Biophys Acta. 1991 Feb 5;1081(3):339-46|||Biochim Biophys Acta. 1991 Apr 24;1083(1):37-45|||J Immunol. 1991 Jul 15;147(2):660-6